BML Capital Management, LLC
- SEC CIK
- 0001616824
- Latest filing
- Aug 7, 2026
AVIR holding history
Atea Pharmaceuticals, Inc. in every 13F filed by BML Capital Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
AVIR overviewAll 13F holders of AVIRFull Q2 2026 holdings
- Shares (Q2 2026)
- 6,952,330
- Value
- $32.3M
- % of portfolio
- 18.5%
- Quarters held
- 13
- Since Q2 2023
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 6,952,330 | $32.3M | 18.5% | −106,327−1.5% | Reduced | Holders |
| Q1 2026 | 7,058,657 | $38.0M | 24.4% | −431,343−5.8% | Reduced | Holders |
| Q4 2025 | 7,490,000 | $26.7M | 23.7% | +16,037+0.2% | Added | Holders |
| Q3 2025 | 7,473,963 | $21.7M | 19.9% | −135,849−1.8% | Reduced | Holders |
| Q2 2025 | 7,609,812 | $27.4M | 21.0% | 00.0% | Unchanged | Holders |
| Q1 2025 | 7,609,812 | $22.8M | 18.4% | +1,5000.0% | Added | Holders |
| Q4 2024 | 7,608,312 | $25.5M | 15.8% | +958,312+14.4% | Added | Holders |
| Q3 2024 | 6,650,000 | $22.3M | 13.1% | +274,379+4.3% | Added | Holders |
| Q2 2024 | 6,375,621 | $21.1M | 15.5% | +838,911+15.2% | Added | Holders |
| Q1 2024 | 5,536,710 | $22.4M | 15.0% | +74,631+1.4% | Added | Holders |
| Q4 2023 | 5,462,079 | $16.7M | 13.2% | +662,079+13.8% | Added | Holders |
| Q3 2023 | 4,800,000 | $14.4M | 13.3% | +2,563,761+114.6% | Added | Holders |
| Q2 2023 | 2,236,239 | $8.36M | 7.5% | +2,236,239 | New | Holders |